Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanifeh Mirtavoos-Mahyari

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Tanaffos|September 6, 2014
Human epidermal growth factor receptor 2 and estrogen receptor status in respect to tumor characteristics in non-metastatic breast cancerHanifeh Mirtavoos-Mahyari, Adnan Khosravi, Zahra Esfahani-Monfared
Nutrition and Cancer|May 3, 2019
Effects of Coffee, Black Tea and Green Tea Consumption on the Risk of Non-Hodgkin's Lymphoma: A Systematic Review and Dose-Response Meta-Analysis of Observational StudiesHanifeh Mirtavoos-Mahyari, Pouya Salehipour, Mohammad Parohan, et al.
Human Antibodies|March 26, 2019
Long non-coding RNAs: Diverse roles in various disordersZahra Azizi, Hanifeh Mirtavoos-Mahyari, Roya Karimi, et al.
Oncotargets and Therapy|May 30, 2014
Two thymus-related autoimmune disorders: a case report and review of the literatureHanifeh Mirtavoos-Mahyari, Adnan Khosravi, Zahra Esfahani-Monfared, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 27, 2018
A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable Price with Clinical BenefitAdnan Khosravi, Babak Salimi, Zahra Esfahani-Monfared, et al.
Iranian Red Crescent Medical Journal|March 13, 2015
Overexpression of HER2/neu as a Prognostic Value in Iranian Women With Early Stage Breast Cancer; A Single Institute StudyHanifeh Mirtavoos Mahyari, Adnan Khosravi, Zeinab Mirtavoos Mahyari, et al.
Frontiers in Genetics|October 9, 2024
A comprehensive in silico analysis and experimental validation of miRNAs capable of discriminating between lung adenocarcinoma and squamous cell carcinomaZahra Javanmardifard, Saeid Rahmani, Hadi Bayat, et al.
Pharmacological Research|March 8, 2020
TGF-β in radiotherapy: Mechanisms of tumor resistance and normal tissues injuryBagher Farhood, Ehsan Khodamoradi, Mojtaba Hoseini-Ghahfarokhi, et al.
Tanaffos|April 7, 2023
T790M and Acquired Resistance of Epidermal Growth Factor Receptor to Tyrosine Kinase Inhibitors in Patients with Lung AdenocarcinomaHanifeh Mirtavoos-Mahyari, Azizollah Abbasi Dezfouli, Zahra Esfahani-Monfared, et al.
Biomolecular Concepts|January 11, 2022
Primary Erlotinib Resistance in a Patient with Non-Small Cell Lung Cancer Carrying Simultaneous Compound EGFR L718A, Q849H, and L858R MutationsHanifeh Mirtavoos-Mahyari, Elham Rismani, Alireza Sarkar Lotfabadi, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Tanaffos|September 6, 2014
Human epidermal growth factor receptor 2 and estrogen receptor status in respect to tumor characteristics in non-metastatic breast cancerHanifeh Mirtavoos-Mahyari, Adnan Khosravi, Zahra Esfahani-Monfared
Nutrition and Cancer|May 3, 2019
Effects of Coffee, Black Tea and Green Tea Consumption on the Risk of Non-Hodgkin's Lymphoma: A Systematic Review and Dose-Response Meta-Analysis of Observational StudiesHanifeh Mirtavoos-Mahyari, Pouya Salehipour, Mohammad Parohan, et al.
Human Antibodies|March 26, 2019
Long non-coding RNAs: Diverse roles in various disordersZahra Azizi, Hanifeh Mirtavoos-Mahyari, Roya Karimi, et al.
Oncotargets and Therapy|May 30, 2014
Two thymus-related autoimmune disorders: a case report and review of the literatureHanifeh Mirtavoos-Mahyari, Adnan Khosravi, Zahra Esfahani-Monfared, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 27, 2018
A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable Price with Clinical BenefitAdnan Khosravi, Babak Salimi, Zahra Esfahani-Monfared, et al.
Iranian Red Crescent Medical Journal|March 13, 2015
Overexpression of HER2/neu as a Prognostic Value in Iranian Women With Early Stage Breast Cancer; A Single Institute StudyHanifeh Mirtavoos Mahyari, Adnan Khosravi, Zeinab Mirtavoos Mahyari, et al.
Frontiers in Genetics|October 9, 2024
A comprehensive in silico analysis and experimental validation of miRNAs capable of discriminating between lung adenocarcinoma and squamous cell carcinomaZahra Javanmardifard, Saeid Rahmani, Hadi Bayat, et al.
Pharmacological Research|March 8, 2020
TGF-β in radiotherapy: Mechanisms of tumor resistance and normal tissues injuryBagher Farhood, Ehsan Khodamoradi, Mojtaba Hoseini-Ghahfarokhi, et al.
Tanaffos|April 7, 2023
T790M and Acquired Resistance of Epidermal Growth Factor Receptor to Tyrosine Kinase Inhibitors in Patients with Lung AdenocarcinomaHanifeh Mirtavoos-Mahyari, Azizollah Abbasi Dezfouli, Zahra Esfahani-Monfared, et al.
Biomolecular Concepts|January 11, 2022
Primary Erlotinib Resistance in a Patient with Non-Small Cell Lung Cancer Carrying Simultaneous Compound EGFR L718A, Q849H, and L858R MutationsHanifeh Mirtavoos-Mahyari, Elham Rismani, Alireza Sarkar Lotfabadi, et al.
Pageof 3